Sana Biotechnology, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Sana Biotechnology, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Sana Biotechnology, Inc. Assets for the quarter ending September 30, 2024 was $559M, a 11.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$559M	-$72M	-11.4%	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$619M	-$88.5M	-12.5%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$681M	-$65.6M	-8.78%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$565M	-$257M	-31.3%	Dec 31, 2023	10-Q	2024-11-08
Q3 2023	$631M	-$267M	-29.7%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$707M	-$264M	-27.2%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$747M	-$301M	-28.7%	Mar 31, 2023	10-Q	2023-05-08
Q4 2022	$823M	-$307M	-27.2%	Dec 31, 2022	10-K	2024-02-29
Q3 2022	$898M	-$335M	-27.1%	Sep 30, 2022	10-Q	2022-11-02
Q2 2022	$971M	-$289M	-22.9%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$1.05B	-$257M	-19.7%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$1.13B	+$399M	+54.7%	Dec 31, 2021	10-K	2023-03-16
Q3 2021	$1.23B			Sep 30, 2021	10-Q	2021-11-08
Q2 2021	$1.26B			Jun 30, 2021	10-Q	2021-08-04
Q1 2021	$1.3B			Mar 31, 2021	10-Q	2021-05-05
Q4 2020	$730M			Dec 31, 2020	10-K	2022-03-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.